XML 31 R17.htm IDEA: XBRL DOCUMENT
v3.20.1

CONSOLIDATED FINANCIAL STATEMENT DETAILS | 3 Months Ended
--- | ---
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
CONSOLIDATED FINANCIAL STATEMENT DETAILS | CONSOLIDATED FINANCIAL STATEMENT DETAILS Cash and Cash Equivalents and Restricted Cash The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheet to the total amounts shown in the consolidated statement of cash flows:
| March 31, 2020 |  | December 31, 2019 |  | March 31, 2019 |  | December 31, 2018
| (In thousands)
Cash and cash equivalents | $ | 2,822,729 |  |  | $ | 3,139,295 |  |  | $ | 2,217,337 |  |  | $ | 2,131,632 |
Restricted cash included in other current assets | 867 |  |  | 654 |  |  | 1,635 |  |  | 1,633 |
Restricted cash included in other assets | 398 |  |  | 409 |  |  | 416 |  |  | 420 |
Total cash and cash equivalents and restricted cash as shown on the consolidated statement of cash flows | $ | 2,823,994 |  |  | $ | 3,140,358 |  |  | $ | 2,219,388 |  |  | $ | 2,133,685 |
Restricted cash at March 31, 2020 and December 31, 2019 primarily consists of a deposit related to corporate credit cards. Restricted cash at March 31, 2019 and December 31, 2018 primarily consists of a cash collateralized letter of credit and a deposit related to corporate credit cards. Accumulated Amortization and Depreciation The following table provides the accumulated amortization and depreciation within the consolidated balance sheet:
Asset Category | March 31, 2020 |  | December 31, 2019
| (In thousands)
Right-of-use assets (included in "other non-current assets") | $ | 59,237 |  |  | $ | 47,815 |
Property, capitalized software and equipment | $ | 335,766 |  |  | $ | 324,359 |
Intangible assets | $ | 237,567 |  |  | $ | 215,198 |
Other (expense) income, net
| Three Months Ended March 31,
| 2020 |  | 2019
| (In thousands)
Other (expense) income, net | $ | (49,893 | ) |  | $ | 651 |
Other expense, net in 2020 includes: $51.5 million in impairments (downward adjustments) related to investments in equity securities without readily determinable fair values and $7.5 million in impairments of a note receivable and a warrant related to certain investees due to the impact of COVID-19; and $10.1 million of interest income. Other income, net in 2019 includes: $12.4 million of interest income; $8.1 million loss related to the sale of a business; and $1.9 million in net foreign currency exchange losses due primarily to the weakening of the U.S. dollar and the Euro relative to the British Pound during the three months ended March 31, 2019.

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration